Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

51 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The right ventricle in pulmonary hypertension.
Chin KM, Kim NH, Rubin LJ. Chin KM, et al. Coron Artery Dis. 2005 Feb;16(1):13-8. doi: 10.1097/00019501-200502000-00003. Coron Artery Dis. 2005. PMID: 15654194 Review.
Central venous blood oxygen saturation monitoring in patients with chronic pulmonary arterial hypertension treated with continuous IV epoprostenol: correlation with measurements of hemodynamics and plasma brain natriuretic peptide levels.
Chin KM, Channick RN, Kim NH, Rubin LJ. Chin KM, et al. Chest. 2007 Sep;132(3):786-92. doi: 10.1378/chest.07-0694. Epub 2007 Jul 23. Chest. 2007. PMID: 17646224
Pulmonary arterial hypertension.
Chin KM, Rubin LJ. Chin KM, et al. J Am Coll Cardiol. 2008 Apr 22;51(16):1527-38. doi: 10.1016/j.jacc.2008.01.024. J Am Coll Cardiol. 2008. PMID: 18420094 Review.
Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension.
Chin KM, Kingman M, de Lemos JA, Warner JJ, Reimold S, Peshock R, Torres F. Chin KM, et al. Am J Cardiol. 2008 Jun 1;101(11):1669-72. doi: 10.1016/j.amjcard.2008.01.055. Epub 2008 Apr 18. Am J Cardiol. 2008. PMID: 18489949
Long-term outcomes with ambrisentan monotherapy in pulmonary arterial hypertension.
Blalock SE, Matulevicius S, Mitchell LC, Reimold S, Warner J, Peshock R, Torres F, Chin KM. Blalock SE, et al. Among authors: chin km. J Card Fail. 2010 Feb;16(2):121-7. doi: 10.1016/j.cardfail.2009.09.008. Epub 2009 Nov 20. J Card Fail. 2010. PMID: 20142023 Free PMC article. Clinical Trial.
Characterizing the right ventricle: advancing our knowledge.
Chin KM, Coghlan G. Chin KM, et al. Am J Cardiol. 2012 Sep 15;110(6 Suppl):3S-8S. doi: 10.1016/j.amjcard.2012.06.010. Am J Cardiol. 2012. PMID: 22921029 Review.
Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.
Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, Naeije R, Newman J, Oudiz RJ, Provencher S, Torbicki A, Voelkel NF, Hassoun PM. Vonk-Noordegraaf A, et al. Among authors: chin km. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D22-33. doi: 10.1016/j.jacc.2013.10.027. J Am Coll Cardiol. 2013. PMID: 24355638 Review.
Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study.
Chin KM, Badesch DB, Robbins IM, Tapson VF, Palevsky HI, Kim NH, Kawut SM, Frost A, Benton WW, Lemarie JC, Bodin F, Rubin LJ, McLaughlin V. Chin KM, et al. Am Heart J. 2014 Feb;167(2):218-225.e1. doi: 10.1016/j.ahj.2013.08.008. Epub 2013 Oct 16. Am Heart J. 2014. PMID: 24439983 Clinical Trial.
51 results
Jump to page
Feedback